Vanguard Group Inc raised its holdings in shares of Calyxt Inc (NASDAQ:CLXT) by 2.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 377,640 shares of the company’s stock after acquiring an additional 7,246 shares during the period. Vanguard Group Inc’s holdings in Calyxt were worth $5,766,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also made changes to their positions in the business. FMR LLC lifted its stake in shares of Calyxt by 40.2% in the 2nd quarter. FMR LLC now owns 4,799,299 shares of the company’s stock valued at $89,603,000 after purchasing an additional 1,375,899 shares during the period. Point72 Asset Management L.P. lifted its stake in shares of Calyxt by 50.0% in the 3rd quarter. Point72 Asset Management L.P. now owns 449,898 shares of the company’s stock valued at $6,870,000 after purchasing an additional 149,898 shares during the period. Columbus Hill Capital Management L.P. lifted its stake in shares of Calyxt by 84.6% in the 3rd quarter. Columbus Hill Capital Management L.P. now owns 308,942 shares of the company’s stock valued at $4,718,000 after purchasing an additional 141,618 shares during the period. BlackRock Inc. lifted its stake in shares of Calyxt by 21.8% in the 2nd quarter. BlackRock Inc. now owns 733,554 shares of the company’s stock valued at $13,696,000 after purchasing an additional 131,265 shares during the period. Finally, Millennium Management LLC acquired a new position in shares of Calyxt in the 2nd quarter valued at $582,000. Institutional investors and hedge funds own 28.60% of the company’s stock.
Several research firms recently issued reports on CLXT. Goldman Sachs Group upgraded shares of Calyxt from a “neutral” rating to a “buy” rating and boosted their target price for the company from $9.25 to $18.00 in a research note on Sunday, December 16th. Zacks Investment Research upgraded shares of Calyxt from a “hold” rating to a “buy” rating and set a $12.00 target price for the company in a research note on Friday, December 21st. Jefferies Financial Group reiterated a “buy” rating and issued a $27.00 target price on shares of Calyxt in a research note on Thursday, November 15th. Finally, Citigroup decreased their target price on shares of Calyxt from $19.00 to $13.00 and set a “neutral” rating for the company in a research note on Monday, November 19th. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Calyxt has an average rating of “Buy” and a consensus target price of $17.75.
Shares of CLXT traded up $0.22 during trading hours on Monday, hitting $13.23. The stock had a trading volume of 5,673 shares, compared to its average volume of 48,064. The company has a debt-to-equity ratio of 0.17, a current ratio of 15.01 and a quick ratio of 15.01. Calyxt Inc has a fifty-two week low of $8.83 and a fifty-two week high of $23.05. The stock has a market cap of $423.77 million, a P/E ratio of -11.81 and a beta of 2.70.
Calyxt (NASDAQ:CLXT) last posted its earnings results on Wednesday, November 14th. The company reported ($0.23) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.29) by $0.06. The firm had revenue of $0.03 million during the quarter, compared to analysts’ expectations of $0.50 million. Calyxt had a negative net margin of 6,256.67% and a negative return on equity of 33.08%. Equities analysts expect that Calyxt Inc will post -0.93 EPS for the current year.
In related news, insider Daniel F. Voytas sold 8,170 shares of the business’s stock in a transaction on Friday, February 1st. The shares were sold at an average price of $13.00, for a total value of $106,210.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Manoj Sahoo sold 2,444 shares of the business’s stock in a transaction on Wednesday, January 2nd. The stock was sold at an average price of $10.39, for a total transaction of $25,393.16. The disclosure for this sale can be found here. In the last three months, insiders sold 15,814 shares of company stock valued at $198,086. 2.80% of the stock is owned by insiders.
ILLEGAL ACTIVITY WARNING: “Vanguard Group Inc Increases Holdings in Calyxt Inc (CLXT)” was first published by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are viewing this story on another publication, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be viewed at https://www.thelincolnianonline.com/2019/02/11/vanguard-group-inc-increases-holdings-in-calyxt-inc-clxt.html.
Calyxt Company Profile
Calyxt, Inc, a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for plants in the United States. It engages in the development of high oleic soybeans, high fiber wheat, herbicide tolerant wheat, powdery mildew resistant wheat, improved oil composition canola, herbicide tolerant canola, improved quality alfalfa and herbicide tolerant alfalfa, late blight resistant potatoes, cold storable/reduced browning potatoes, improved protein composition soybeans, drought tolerant soybeans, herbicide tolerant soybeans, and improved yield soybeans.
Want to see what other hedge funds are holding CLXT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Calyxt Inc (NASDAQ:CLXT).
Receive News & Ratings for Calyxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calyxt and related companies with MarketBeat.com's FREE daily email newsletter.